Oncocyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oncocyte and other ETFs, options, and stocks.

About OCX

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.

CEO

Joshua Riggs

CEOJoshua Riggs

Employees

Employees49

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

2009

Founded2009

Employees

Employees49

OCX Key Statistics

Market cap

84.94M

Market cap84.94M

Price-Earnings ratio

-0.67

Price-Earnings ratio-0.67

Dividend yield

—

Dividend yield—

Average volume

26.44K

Average volume26.44K

High today

$3.02

High today$3.02

Low today

$2.82

Low today$2.82

Open price

$2.82

Open price$2.82

Volume

28.02K

Volume28.02K

52 Week high

$4.75

52 Week high$4.75

52 Week low

$1.92

52 Week low$1.92

Oncocyte

Why Robinhood?

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. Show more

OCX Key Statistics

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.